Neothetics ponders the future after sole therapy proves an ugly flop in PhII, eviscerating shares
Back in 2014, San Diego-based Neothetics raised $65 million by selling shares at $14 a pop after winning over a group of investors to back …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
